ARCHIVES

New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Boyd’s Rebuttal to DePinho’s Letter to the AAUP

May 30, 2014

New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White

November 30, 1984

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

Ohio State recruits neurosurgeon from Harvard to lead new department.

January 9, 2004

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989